Log on / register
Feedback | Support | My details
Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases.
Twum-Danso NA
Filaria J 2003, 2 Suppl 1:S3
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
36%36%


 Research    
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control
Thomson MC, Obsomer V, Kamgno J, Gardon J, Wanji S, Takougang I, Enyong P, Remme JH, Molyneux DH, Boussinesq M
Filaria Journal 2004, 3:7 (6 August 2004)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.
36%36%


 Short paper    
Failed attempts at experimental transplantation and transmission of nocturnally-periodic simian Loa from monkey to man
Duke BOL
Filaria Journal 2004, 3:5 (29 July 2004)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.
36%36%


 Short paper    
Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study
Higazi TB, Klion AD, Boussinesq M, Unnasch TR
Filaria Journal 2004, 3:4 (29 June 2004)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.
36%36%


 Review    
Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future
Twum-Danso NAY
Filaria Journal 2003, 2(Suppl 1):S7 (24 October 2003)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
5.
36%36%


 Editorial    
Overview: Report of a Scientific Working Group on Serious Adverse Events following Mectizan® treatment of onchocerciasis in Loa loa endemic areas.
Duke BOL
Filaria Journal 2003, 2(Suppl 1):S1 (24 October 2003)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.